In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this latest episode, DDW’s Megan Thomas is in conversation with two experts when it comes to clinical trials. First up is Livia Ng, CEO and Founder of Neuroute. At just 24 years old, Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development.
Thereafter, Thomas spoke with CEO of Trialbee, Matt Walz. Walz was recently selected in the 2022 PharmaVoice 100 for the company’s innovative work in the space, and speaks about how real world data can help to boost diversity rates in clinical trials.